Cargando…
Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis
Asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), impairs the beneficial effect of NO. The predictive value of ADMA for all-cause mortality remains controversial, though it is important in the development of cardiovascular disease (CVD) and progression to...
Autores principales: | Zhou, Shaoli, Zhu, Qianqian, Li, Xiang, Chen, Chaojin, Liu, Jiping, Ye, Yuping, Ruan, Ying, Hei, Ziqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353714/ https://www.ncbi.nlm.nih.gov/pubmed/28294182 http://dx.doi.org/10.1038/srep44692 |
Ejemplares similares
-
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
por: Czarnecka, Anna, et al.
Publicado: (2016) -
Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020) -
Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022) -
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
por: Erre, Gian Luca, et al.
Publicado: (2019)